Speaker illustration

Professor Jaakko Tuomilehto

Finnish Institute for Health and Welfare (THL), Helsinki (Finland)

Member of:

European Society of Cardiology

Professor Jaakko Tuomilehto, MD, MA (sociology), PhD, FRCP(Edin), FESC is Professor Emeritus of Public Health of University of Helsinki, Finland and is affiliated with the Finnish Institute for Health and Welfare in Helsinki, Finland. His research interests include the epidemiology and prevention of non-communicable diseases such as diabetes, cardiovascular disease (CVD), cancer and dementia. He has contributed many landmark scientific research projects. He started his research career with the North Karelia Project in Finland, the first community-based prevention programme for CVD. He initiated the Finnish Diabetes Prevention Study (DPS) that demonstrated a 58% reduction in incidence type 2 diabetes with lifestyle intervention. This finding was later confirmed by similar trials from many countries. He has contributed to over 1900 scientific publications. His h-index is 229. He has received many prestigious scientific awards, f. ex. ESC Geoffrey Rose Award.

Lifestyle interventions to effectively reduce cardiovascular risk in the prediabetic patient: an illusion?

Event: ESC Congress 2022

Topic: Diabetes and the Heart

Session: All you need to know about your prediabetic patient: making the diagnosis and reducing risk


Individual risk prediction in patients with type 2 diabetes mellitus

Event: EuroPrevent 2019

Topic: Cardiovascular Risk Assessment

Session: Using risk calculators for personalizing cardiovascular disease prevention: how, for whom, and when?


Prevention of diabetes and its pre-states.

Event: EuroPrevent 2019

Topic: Diabetes and the Heart

Session: Masterclass on Diabetes & CV Risk Part 1: The patient with diabetes


Diet in patients with metabolic syndrome - Low carb or low cholesterol?

Event: ESC Congress 2017

Topic: Nutrition

Session: Eating your way through prevention


Epidemiology of diabetes and cardiovascular disease.

Event: ESC Congress 2013

Topic: Diabetes, dysglycaemia and metabolic syndrome

Session: ESC Guidelines on diabetes, pre-diabetes and cardiovascular disease


ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb